Mohassel et al. identified specific variants in the SPTLC1 gene that cause the loss of ORMDL-mediated inhibitory control over the SPT complex, leading to unrestricted synthesis of sphingolipid bases and resulting in a monogenic form of ALS manifesting in childhood [205]. The gene discussed is SPTLC1; the disease is amyotrophic lateral sclerosis.